EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy

Andrea Marcellusi, Fabio Calabrò, Anna Maria Di Giacomo, Fabio Puglisi, Alessio Cortellini, Isobel Thornton, Yan Zhi Tan, Alessandro Catanzaro, Catarina Neves, Fabrizio Ascone, Matilde Franceschini, Mario Calandriello und 2 weitere

Clinical Drug Investigation · 2026-08 · 46 (8) · 869-881

DOI: 10.1007/s40261-026-01567-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Drug Investigation, online erschienen am 06.06.2026. Verfasst von Andrea Marcellusi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences-DISFARM, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MSD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmune Checkpoint InhibitorsHumansItalyFemaleNeoplasm StagingMarkov ChainsCost-Benefit AnalysisNeoadjuvant TherapyQuality of LifeQuality-Adjusted Life Years

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences-DISFARM, University of Milan, Milan, Italy.
  • Department of Medical Oncology 1, National Cancer Institute Regina Elena, IRCCS, Rome, Italy.
  • Center for Immuno-Oncology, University Hospital of Siena, University of Siena, Siena, Italy.
  • Department of Medical Oncology, National Cancer Institute, Centro di Riferimento Oncologico RCCS, Aviano, Italy.
  • Department of Medicine, University of Udine, Udine, Italy.
  • Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.

Förderung

  • MSD

Zitieren

APA

Marcellusi, A., Calabrò, F., Di Giacomo, A. M., Puglisi, F., Cortellini, A., Thornton, I., Tan, Y. Z., Catanzaro, A., Neves, C., Ascone, F., Franceschini, M., Calandriello, M., Aguiar-Ibáñez, R., & Lai, Y. (2026). Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy. Clinical Drug Investigation, 46(8), 869-881. https://doi.org/10.1007/s40261-026-01567-7

Vancouver

Marcellusi A, Calabrò F, Di Giacomo AM, Puglisi F, Cortellini A, Thornton I, et al. Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy. Clinical Drug Investigation. 2026;46(8):869-881. doi:10.1007/s40261-026-01567-7

BibTeX
@article{Marcellusi2026,
  author = {Marcellusi, Andrea and Calabrò, Fabio and Di Giacomo, Anna Maria and Puglisi, Fabio and Cortellini, Alessio and Thornton, Isobel and Tan, Yan Zhi and Catanzaro, Alessandro and Neves, Catarina and Ascone, Fabrizio and Franceschini, Matilde and Calandriello, Mario and Aguiar-Ibáñez, Raquel and Lai, Yizhen},
  title = {Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy},
  journal = {Clinical Drug Investigation},
  year = {2026},
  volume = {46},
  number = {8},
  pages = {869--881},
  doi = {10.1007/s40261-026-01567-7}
}
Kostenlos starten →